Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 3, 1997

View Archived Issues

Genzyme Tissue Repair: Q3 1997 highlights

Genzyme Transgenics: Q3 1997 highlights

Celtrix: Q2 1997 highlights

Penederm: Q3 and nine-month 1997 highlights

Anika: Q3 1997 highlights

ImmuCell: Q3 1997 highlights

Laminin-like peptides available for licensing from NIH

New chemical candidate for treating cocaine addiction

Oxazolidinone antibacterial agents prepared at P&U

Merck KGaA reports two new series of ET antagonists

Samjin develops nucleosides for HIV

Vasopressin V1a receptor antagonists claimed for obsessive-compulsive disorder

New orally active thrombin inhibitors from Merck & Co.

nAChR ligands prepared at Astra

Clinical data reported for Actiq

Phase II results promising for E-047/1 following CABG

Effect of AMPA antagonist GYKI-52466 on oxygen balance in ischemic cortex

Clevidipine lowers MAC of anesthetic in animal study

Promising interim safety and efficacy data reported for Gd-Tex

Pharmacokinetics of anti-CD11b MAb in patients undergoing aneurysm repair

Initial results show Ethyol effective in reducing radiation-induced xerostomia

Human safety, immunogenicity and pharmacokinetics reported for h5G1.1-scFV

U.K. launch for Malarone, a potent new antimalarial combination

Genzyme General and Acadia enter drug discovery collaboration

Grant supports p53 gene research at The Wistar Institute

FibroGen granted license to Zeneca antifibrotic compounds

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Pamidronate for preventing glucocorticoid-induced osteoporosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...